Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (1,589,432) $ (2,955,294)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 73,901
Change in inventory value 156,600 161,440
Gain on forgiveness of PPP loan (279,191)
Stock-based compensation 906,919 1,929,446
Bad debt expense 78,125 125,625
Changes in operating assets and liabilities:    
Accounts receivable 154,840 265,106
Prepaid expenses and other assets (59,086) (6,312)
Inventory 475,000
Accounts payable and accrued liabilities 371,076 (241,840)
Deferred revenue (174,250) (566,500)
Net cash used in operating activities (434,399) (739,428)
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from common stock placement 725,050 525,000
Proceeds from notes payable 139,595
Proceeds from shareholder advance   100,000
Net cash provided by financing activities 725,050 764,595
Net (decrease) increase in cash 290,651 25,167
Cash, beginning of period 71,075 376,425
Cash, end of period 361,726 401,592
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:    
Shares issued for equity financing 250,000
Commitment shares issued in conjunction with capital raise 200,000
Shares issued for vested restricted stock units $ 108 $ 505